Bristol-Myers Squibb Crosses Above its 10-day MA (BMY) Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. In the past 52 weeks, shares of Bristol-Myers Squibb have traded ... |
